STOCK TITAN

Alyeska Group takes 9.99% position in Battalion Oil (BATL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

BATTALION OIL CORP reports an ownership disclosure by Alyeska Investment Group and affiliates holding 1,872,282 shares of Common Stock, equal to 9.99% of the class as of 03/31/2026.

The position comprises 1,800,000 shares acquired in a private placement and 72,282 shares issuable upon exercise of pre-funded warrants. The pre-funded warrants are exercisable for 927,273 shares but include a 9.99% beneficial ownership limitation that permits exercise of only 72,282 warrant shares based on 18,741,563 shares outstanding (per the Form 424B3 Prospectus dated 04/02/2026).

Positive

  • None.

Negative

  • None.

Insights

Alyeska disclosed a 9.99% stake limited by pre-funded warrant caps.

The filing shows a combined position of 1,872,282 shares (9.99%) held by Alyeska entities as of 03/31/2026, including a private placement and exercisable pre-funded warrants. The warrants total 927,273 shares but contain a contractual cap that prevents exercise beyond the 9.99% threshold.

Future incremental ownership depends on outstanding share count and any changes to the beneficial ownership limitation; subsequent filings would show if additional exercises occur or if the ownership cap is amended.

Disclosure follows Rule 13d-1(k) joint filing conventions and attributes voting power to the investment manager.

The statement attributes shared voting and dispositive power of 1,872,282 shares to Alyeska Investment Group, L.P., notes attribution to Alyeska Master Fund, L.P., and records a disclaimer by Anand Parekh. A joint filing clause is included for amendment responsibility.

Cash‑flow treatment of the private placement and warrant mechanics are described; any change to outstanding shares or warrant terms would alter exercisability under the 9.99% cap.

Beneficial ownership 1,872,282 shares as of 03/31/2026
Percent of class 9.99% based on 18,741,563 shares outstanding
Private placement shares 1,800,000 shares acquired in a private placement
Warrant shares issuable 72,282 shares issuable upon exercise of pre-funded warrants (exercisable given 9.99% limit)
Total pre-funded warrants 927,273 shares warrants exercisable in principal but subject to ownership cap
Shares outstanding (source) 18,741,563 shares per Form 424B3 Prospectus dated 04/02/2026
pre-funded warrants financial
"issuable upon exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficial ownership limitation regulatory
"warrants contain a beneficial ownership limitation that prohibits exercise"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
private placement financial
"1,800,000 shares acquired in a private placement"
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
Rule 13d-1(k) regulatory
"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





07134L107

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alyeska Investment Group, L.P.
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:05/15/2026
Alyeska Fund GP, LLC
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:05/15/2026
Anand Parekh
Signature:Anand Parekh
Name/Title:Anand Parekh | Self
Date:05/15/2026
Exhibit Information

As of March 31, 2026, the Reporting Persons beneficially own 1,872,282 shares of Common Stock, consisting of (i) 1,800,000 shares acquired in a private placement and (ii) 72,282 shares issuable upon exercise of pre-funded warrants. The Reporting Persons hold pre-funded warrants exercisable for 927,273 shares; however, such warrants contain a beneficial ownership limitation that prohibits exercise to the extent it would cause the holder's beneficial ownership to exceed 9.99% of the outstanding Common Stock. Based on 18,741,563 shares of Common Stock outstanding (per the Form 424B3 Prospectus dated April 2, 2026), the 9.99% limitation permits exercise of only 72,282 warrant shares after giving effect to the 1,800,000 shares otherwise held. Position held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control over the shares held by Alyeska Master Fund, L.P. Anand Parekh, as Chief Executive Officer of Alyeska Investment Group, L.P., may be deemed the beneficial owner of such shares. Mr. Parekh disclaims beneficial ownership of such shares. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

FAQ

What stake does Alyeska hold in Battalion Oil Corp (BATL)?

Alyeska beneficially owns 1,872,282 shares, equal to 9.99% of the class. This includes 1,800,000 shares from a private placement and 72,282 shares issuable upon exercise of pre-funded warrants as of 03/31/2026.

How many shares are issuable under Alyeska's pre-funded warrants?

Pre-funded warrants are exercisable for 927,273 shares overall. However, a 9.99% beneficial ownership limitation permits exercise of only 72,282 warrant shares given 18,741,563 shares outstanding per the 04/02/2026 prospectus.

What is the outstanding share count used to calculate the 9.99% cap?

The filing cites 18,741,563 shares outstanding. That figure is taken from the Form 424B3 Prospectus dated 04/02/2026 and is the basis for computing exercisable warrant shares under the 9.99% limitation.

Who exercises voting and investment control over these shares?

Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control. The position is held by Alyeska Master Fund, L.P.; Anand Parekh is identified as CEO of the manager and disclaims beneficial ownership of the fund's shares.

Does the filing create a joint reporting arrangement?

Yes. The filing includes a joint filing statement under Rule 13d-1(k). The undersigned agree subsequent amendments will be filed on behalf of each and accept responsibility for timely and accurate amendment of their respective information.